JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
Want to see HK:2126 full AI Analyst Report?
Comparison Results
Alphamab Oncology
HK$11.90
HK$8.57B
-76.25
4.12%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.08B
9.33
6.51%
1 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$3.87B
-3.21
-40.94%
―
CStone Pharmaceuticals
HK$5.34
HK$12.42B
-15.04
115.59%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.01
HK$3.77B
406.71
-43.68%
―
Performance Comparison
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.03
0.30
17.34%
HK:9966
Alphamab Oncology
9.35
0.45
5.06%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.58
0.14
3.15%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.15
-3.40
-39.77%
HK:2616
CStone Pharmaceuticals
8.02
4.48
126.55%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
6.06
-4.24
-41.17%